Abbott Laboratories (ABT) Non-Current Debt (2009 - 2026)
Abbott Laboratories (ABT) posted Non-Current Debt of $29.6 billion for Q2 2026, little changed sequentially from $29.6 billion in Q1 2026, and up 128.95% YoY from $12.9 billion in Q2 2025.
Abbott Laboratories (ABT) Non-Current Debt (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Non-Current Debt for 18 years, with the latest figure at $29.6 billion in Q2 2026.
- Quarterly Non-Current Debt rose 128.95% year-over-year to $29.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $29.6 billion (up 128.95% YoY) and the FY2025 annual result came in at $9.9 billion, down 29.94% from the prior year.
- Non-Current Debt was little changed at $29.6 billion in Q2 2026 per ABT's latest filing, from $29.6 billion in the prior quarter.
- Over five years, Non-Current Debt peaked at $29.6 billion in Q1 2026 and troughed at $9.9 billion in Q4 2025.
- A 5-year average of $15.7 billion and a median of $14.5 billion in 2023 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2025 and 2026: Non-Current Debt dropped 29.94% in 2025, then surged 132.71% in 2026.
- Over 5 years, Non-Current Debt stood at $16.8 billion in 2022, then dropped by 12.48% to $14.7 billion in 2023, then decreased by 3.77% to $14.1 billion in 2024, then declined by 29.94% to $9.9 billion in 2025, then jumped by 199.14% to $29.6 billion in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $29.6 billion, $29.6 billion, and $9.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Zimmer Biomet Holdings | 19.32 Bn | 18.91 Bn | 1.54 Bn | 6.28 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.60 Bn |
| Mar 31, 2026 | 29.64 Bn |
| Dec 31, 2025 | 9.90 Bn |
| Sep 30, 2025 | 11.60 Bn |
| Jun 30, 2025 | 12.93 Bn |
| Mar 31, 2025 | 12.74 Bn |
| Dec 31, 2024 | 14.13 Bn |
| Sep 30, 2024 | 12.83 Bn |
| Jun 30, 2024 | 13.14 Bn |
| Mar 31, 2024 | 12.58 Bn |
| Dec 31, 2023 | 14.68 Bn |
| Sep 30, 2023 | 14.48 Bn |
| Jun 30, 2023 | 14.56 Bn |
| Mar 31, 2023 | 14.62 Bn |
| Dec 31, 2022 | 16.77 Bn |
| Sep 30, 2022 | 15.30 Bn |
| Jun 30, 2022 | 16.76 Bn |
| Mar 31, 2022 | 17.09 Bn |
| Dec 31, 2021 | 18.05 Bn |
| Sep 30, 2021 | 17.45 Bn |